Produktname:3,6-Dihydroxyacridin-9(10H)-one

IUPAC Name:3,6-dihydroxy-9,10-dihydroacridin-9-one

CAS:122105-95-7
Molekulare Formel:C13H9NO3
Reinheit:97%
Katalognummer:CM489495
Molekulargewicht:227.22

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM489495-1g in stock țȁȬȬ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:122105-95-7
Molekulare Formel:C13H9NO3
Schmelzpunkt:-
SMILES-Code:O=C1C2=C(C=C(O)C=C2)NC3=CC(O)=CC=C13
Dichte:
Katalognummer:CM489495
Molekulargewicht:227.22
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Acridines
Acridines are organic compounds and nitrogen heterocycles having the formula C13H9N. Acridine is a substituted derivative of the parent ring. It is a planar molecule structurally related to anthracene in which one carbon in the central CH group is replaced by nitrogen. Acridine and its derivatives can be used to make dyes and also used in the pharmaceutical industry. Acridine is a DNA intercalator that easily binds to DNA. Due to its DNA-intercalating properties, acridine or its suitable derivatives are expected to preferentially accumulate in tumors, which are always associated with enhanced DNA replication. Therefore, radiolabeled acridines may have prospect in tumor imaging.

Related Products



Product Other Information

Product Overview 3,6-Dihydroxyacridin-9(10H)-one is a synthetic compound that has gained attention in the field of medicinal chemistry due to its potential as a therapeutic agent. 3,6-Dihydroxyacridin-9(10H)-one belongs to the class of acridine derivatives and has been found to exhibit a range of biological activities.
Chemical Properties 3,6-Dihydroxyacridin-9(10H)-one is a reactive compound, often utilized as a starting material or intermediate in various chemical reactions and synthesis processes.
Synthesis and Application 3,6-Dihydroxyacridin-9(10H)-one has been extensively studied for its potential as a therapeutic agent in various diseases. It has been found to exhibit anti-cancer, anti-viral, and anti-inflammatory activities. 3,6-Dihydroxyacridin-9(10H)-one has been shown to inhibit the growth of various cancer cell lines, including breast, lung, and colon cancer cells. It has also been found to inhibit the replication of HIV-1 virus and reduce the production of pro-inflammatory cytokines in vitro.